One-Pot Synthesis of Affordable Redox-Responsive Drug Delivery System Based on Trithiocyanuric Acid Nanoparticles

Nano Lett. 2023 Dec 13;23(23):10811-10820. doi: 10.1021/acs.nanolett.3c02933. Epub 2023 Nov 21.

Abstract

Redox-responsive drug delivery systems present a promising avenue for drug delivery due to their ability to leverage the unique redox environment within tumor cells. In this work, we describe a facile and cost-effective one-pot synthesis method for a redox-responsive delivery system based on novel trithiocyanuric acid (TTCA) nanoparticles (NPs). We conduct a thorough investigation of the impact of various synthesis parameters on the morphology, stability, and loading capacity of these NPs. The great drug delivery potential of the system is further demonstrated in vitro and in vivo by using doxorubicin as a model drug. The developed TTCA-PEG NPs show great drug delivery efficiency with minimal toxicity on their own both in vivo and in vitro. The simplicity of this synthesis, along with the promising characteristics of TTCA-PEG NPs, paves the way for new opportunities in the further development of redox-responsive drug delivery systems based on TTCA.

Keywords: drug delivery; glutathione-responsive nanoparticles; redox-responsive nanoparticles; trithiocyanuric acid.

MeSH terms

  • Doxorubicin / therapeutic use
  • Drug Carriers
  • Drug Delivery Systems* / methods
  • Nanoparticles*
  • Oxidation-Reduction

Substances

  • trithiocyanuric acid
  • 2-thioxo-4-thiazolidinecarboxylic acid
  • Doxorubicin
  • Drug Carriers